Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Travere Therapeutics Inc Is A Biopharmaceutical Company. The Company Is Focused On Identifying, Developing And Delivering Life-Changing Therapies To People Living With Rare Kidney, Liver, And Metabolic Diseases. Its Pipeline Candidate, Sparsentan, Is An Investigational Product Candidate In Late-Stage Development For Focal Segmental Glomerulosclerosis (Fsgs) And Iga Nephropathy (Igan)-Rare Kidney Disorders That Often Cause End-Stage Kidney Disease. It Is Also Advancing Pegtibatinase, A Novel Investigational Enzyme Replacement Therapy For The Treatment Of Hcu, A Genetic Disorder Caused By A Deficiency In A Pivotal Enzyme Essential To The Body.